- Home
- LRMR vs OOMA Comparison
LRMR vs OOMA Comparison
Compare LRMR & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LRMR | OOMA |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 517.6M |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LRMR | OOMA |
|---|---|---|
| Price | $3.47 | $17.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $16.50 | ★ $18.77 |
| AVG Volume (30 Days) | ★ 2.0M | 331.8K |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 188.46 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $114,490,000.00 |
| Revenue This Year | N/A | $20.35 |
| Revenue Next Year | $1,816.14 | $4.17 |
| P/E Ratio | ★ N/A | $192.44 |
| Revenue Growth | N/A | ★ 9.53 |
| 52 Week Low | $2.26 | $9.79 |
| 52 Week High | $6.42 | $21.96 |
Technical Indicators
Market Signals| Indicator | LRMR | OOMA |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 50.33 |
| Support Level | $3.10 | $10.78 |
| Resistance Level | $3.74 | $19.56 |
| Average True Range (ATR) | 0.20 | 1.05 |
| MACD | 0.06 | -0.15 |
| Stochastic Oscillator | 81.29 | 23.73 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.